Skip to main content
Clinical Trials/NCT04035902
NCT04035902
Unknown
Phase 4

Intraoperative IV Iron on the Postoperative Recovery of Red Blood Cell in Hip Arthroplasty Surgery

Konkuk University Medical Center0 sites46 target enrollmentMarch 2021

Overview

Phase
Phase 4
Intervention
Ferric carboxymaltose
Conditions
Osteoarthritis, Hip
Sponsor
Konkuk University Medical Center
Enrollment
46
Primary Endpoint
postoperative hematocrit (%)
Last Updated
5 years ago

Overview

Brief Summary

The objective of the present study is to determine the impact of intraoperative IV-iron supplementation on postoperative recovery of RBC mass by retrospectively analyzing and comparing the changes of postoperative hematocrit values after the surgery in patients underwent elective uni-limb total knee arthroplasty surgery with or without IV-iron supplementation during surgery

Registry
clinicaltrials.gov
Start Date
March 2021
End Date
December 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tae-Yop Kim, MD PhD

Professor Anesthesiology

Konkuk University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

ferric carboxymaltose 1000 mg

Ferric carboxymaltose is administered during surgery

Intervention: Ferric carboxymaltose

control

Ferric carboxymaltose is not administered

Intervention: control

Outcomes

Primary Outcomes

postoperative hematocrit (%)

Time Frame: 7 days after surgery

hematocrit is evaluated on postoperative 7 days

Secondary Outcomes

  • volume of post-operative bleeding (ml)(7 day)
  • intraoperative blood transfusion (ml)(1 day)
  • post-operative blood transfusion (ml)(7 days)
  • post-operative serum ferritin level (ng/ml)(1 day)

Similar Trials